This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Discover which index funds have the lowest fees for IRAs and how they compare, plus practical tips to minimize costs and boost your retirement balance.
27,073 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
The Federal Reserve keeps rates unchanged as Powell's tenure nears its end, citing inflation risks and global tension...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...
America marks 250 years with a focus on risk-sharing as the true engine of progress. The greatest lesson may be the b...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
U.S. oil drillers added two rigs to 431, marking six straight weeks of growth—the longest run since mid-2022. Prices ...
Ethereum hovers near a pivotal price zone as traders await a breakout. A decisive move above the key level could spar...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
A fresh analysis shows WisdomTree's WCLD underperforms due to equal-weight rebalancing, turning a $10,000 stake into ...
Delaware announces a plan to create a new legal form for AI-driven firms—the Autonomous AI Company (AIC)—to be triale...